Related Experiment Video

Updated: Aug 18, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Targeting cancer cells by exploiting karyotypic complexity and chromosomal instability

Anna V Roschke1, Ilan R Kirsch

  • 1Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Cell Cycle (Georgetown, Tex.)
|April 23, 2005
PubMed

Insights

Cancer cells with complex and unstable chromosomes may be targeted by new chemotherapy drugs. This study identifies compounds that are more effective against these specific cancer types, offering a new approach to drug discovery.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Many cancers exhibit chromosomal abnormalities and instability, contributing to resistance against conventional chemotherapy.
  • Current anticancer drug discovery often focuses on specific genes or pathways.

Purpose of the Study:

  • To investigate if karyotypic complexity and instability can serve as criteria for screening potential anticancer compounds.
  • To identify novel therapeutic strategies for chemoresistant cancers.

Main Methods:

  • Utilized a panel of well-characterized cancer cell lines with varying degrees of karyotypic complexity and instability.
  • Screened chemical compounds for differential cytotoxicity against these cell lines.

Main Results:

  • Identified specific chemical compounds demonstrating higher cytotoxicity towards cancer cell lines with greater karyotypic complexity and instability.
  • Demonstrated a correlation between chromosomal abnormalities and sensitivity to certain chemical agents.

Conclusions:

  • Karyotypic complexity and instability can be effectively used as determinants for screening anticancer compounds.
  • This approach offers a complementary strategy to gene- or pathway-focused drug discovery for identifying lead compounds against chemoresistant cancers.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes05:22

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes

Published on: April 13, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...